Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Analysis of DNA methylation associates the cystine–glutamate antiporter SLC7A11 with risk of Parkinson’s disease

6 Mar 2020

Abstract excerpt

An improved understanding of etiological mechanisms in Parkinson's disease (PD) is urgently needed because the number of affected individuals is projected to increase rapidly as populations age. We present results from a blood-based methylome-wide association study of PD involving meta-analysis of 229 K CpG probes in 1,132 cases and 999 controls from two independent cohorts. We identify two previously unreported...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Amino Acid Enzymes and Metabolism
Share to Epigenetics and DNA Methylation
Share to Parkinson's Disease Mechanisms and Treatments

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 32144264
DOI: 10.1038/s41467-020-15065-7

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 9 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Analysis of DNA methylation associates the cystine–glutamate antiporter SLC7A11 with risk of Parkinson’s diseasePMID 32144264Read ↗

No genetic evidence for <i>SLC7A11</i> involvement in Parkinson’s DiseaseSemantic proximity Read ↗

Parkinson’s disease-associated alterations in DNA methylation and hydroxymethylation in human brainSemantic proximity Read ↗

Parkinson’s disease-associated alterations in DNA methylation and hydroxymethylation in human brainSemantic proximity Read ↗

DNA methylation as a mediator of genetic and environmental influences on Parkinson’s disease susceptibility: Impacts of alpha-Synuclein, physical activity, and pesticide exposure on the epigenomeSemantic proximity Read ↗

Implications of DNA Methylation in Parkinson’s DiseaseSemantic proximity Read ↗

DNA methylation changes associated with Parkinson’s disease progression: outcomes from the first longitudinal genome-wide methylation analysis in bloodSemantic proximity Read ↗

DNA Methyltransferase 1 Is Dysregulated in Parkinson’s Disease via Mediation of miR-17Semantic proximity Read ↗

Alpha-synuclein induces epigenomic dysregulation of glutamate signaling and locomotor pathwaysSemantic proximity Read ↗

Methylated Cytochrome P450 and the Solute Carrier Family of Genes Correlate With Perturbations in Bile Acid Metabolism in Parkinson’s DiseaseSemantic proximity Read ↗

Characterization of baseline and longitudinal DNA Methylation in patients with sporadic Parkinsons diseaseSemantic proximity Read ↗

Epigenetic regulation in Parkinson's disease.Semantic proximity Read ↗

Alterations in Blood Methylome as Potential Epigenetic Biomarker in Sporadic Parkinson's DiseaseSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.